about
Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...
Read More
2046.60
15.40
(0.76%)
479.3K
NSE+BSE Volume
NSE 18 Sep, 2025 3:31 PM (IST)
US FDA Observation
Lupin receives Form 483 with six observations from the US FDA for its Nagpur injectable facility
See details